Latest News
Redhall attributes share price jump to Hinkley Point approval
AIM-listed manufacturing and specialist services company Redhall Group noted the jump in its share price on Thursday, saying it was likely to be related to the government’s approval of the Hinkley Point C nuclear power station.
Cronin Group's H1 losses narrows as it aims to digitise chemistry
Chemical drug discovery company Cronin Group’s half year losses narrowed as it aims to digitise chemistry for manufacturing and algorithm-driven discovery.
Canaccord cuts Dunelm to 'hold' from 'buy'
Canaccord Genuity on Thursday lowered its rating on Dunelm to ‘hold’ from ‘buy’ but raised its target price to 920p from 875p after the homeware retailer reported its full year results.
Liberum downgrades Hargreaves Lansdown, points to consensus downgrades
Liberum downgraded Hargreaves Lansdown to ‘sell’ from ‘buy’ pointing to further downside risks.
UK retail sales for August better than feared
Retail sales in the UK were not as bad as feared in August, according to official figures released on Wednesday, further lowering the likelihood that the Bank of England will adjust interest rates later in the day.
Clinton doctor declares Democrat candidate "fit to serve"
Hillary Clinton's doctor has provided additional medical information for the Democrat nominee in the US presidential election, saying that she is in good health having recovered well from pneumonia.
UBS ups Fresnillo to 'neutral' on more balanced risk/reward
UBS upgraded Fresnillo to ‘neutral’ from ‘sell’ with an unchanged target price of 1,600p saying the risk/reward was now more balanced after a 20% correction in the shares since the July peak.
Europe open: Stocks drift lower as investors mull central bank policy
European stocks drifted a little lower in early trade as investors continued to mull over the direction of central bank policy.
JRP ups guidance as merger benefits ahead of schedule
Retirement service provider JRP Group, the newly merged Just Retirement and Partnership Assurance, raised its target for synergies from the deal as it delivered benefits ahead of schedule.
GlaxoSmithKline's shingles vaccine proves highly effective
After its Shingrix shingles vaccine proved extremely successful in a trial among elderly patients, GlaxoSmithKline has begun planning regulatory applications for later this year.
Booker sales speed up in second quarter helped by Budgens and Londis
Sales accelerated in the second quarter for wholesaler and retailer Booker, keeping the company on course to meet full year targets.
Informa to buy US rival Penton for £1.2bn
Informa, the business intelligence, events and academic publishing company, has agreed to buy US-based peer Penton Information Services for £1. 2bn.
London open: Stocks little changed ahead of BoE announcement
Stocks in London were little changed in early trade as investors looked to the latest policy announcement from the Bank of England.
UK approves plan to develop Hinkley Point nuclear power station
The UK government has given the go-head for construction of the £18bn Hinkley Point C nuclear power project to France's EDF, but added several conditions.
Electrocomponents expects solid increase in H1 profit
FTSE 250 electronics distributor Electrocomponents said on Thursday that it expects to post a significant increase in first-half pre-tax profit following stronger-than-anticipated trading.
Directory carries Next while retail earnings slump
High street fashion stalwart Next showed sales growth across the business in its half-year results on Thursday, but earnings were still facing an uphill battle in its retail division.
EnQuest, Delek Group end talks over Kraken development
Oil producer EnQuest has ended talks with Israel’s Delek Group over a potential sale of a stake in the Kraken development in the North Sea.
Newspaper round-up: Bayer, Monsanto, Ford, Biffa
Bayer has agreed a $66bn Monsanto deal to create an agrichemicals giant. The combined business will have annual revenues of $23bn and dominate a sector which has seen a wave of consolidation as falling crop prices trigger tie-ups in the hunt for efficiencies. In the past year DuPont and Dow Chemical agreed to merge, and China National Chemical Corp inked a deal to buy Syngenta, which for years had been eyed by Monsanto. - Telegraph.